Health TrialsbyHealthPanel

Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care

ConditionsCardiovascular ComplicationCardiovascular InsufficiencyCardiac ComplicationOncologic ComplicationsCardiac InsufficiencyMetabolic DisorderVascular DisorderCardiac Disorder
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorGroupe Hospitalier Pitie-Salpetriere

About this trial

Several Drugs used in routine care in oncology induce rare but often severe or fatal cardiovascular or metabolic side effects. This study will investigate, evaluate, report and treat the cardiovascular side effects of anticancer drugs, through a specific cardiovascular routine checkup and follow-up taking place in several Cardio-oncology programs throughout France. The different including centers will be: Assistance Publique - Hôpitaux de Paris (APHP.6: Pitié-Salpétrière, Saint Antoine and Tenon's hospitals, Paris, France).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Suffering a cancer

Evaluated within a cardio-oncology program

Disqualifiers

None

Trial population

Patients suffering (or having suffered) from a cancer

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Anti-Cancer Agents

    Drug

    Drugs and treatments used in cancer inducing cardiovascular and metabolic side effects

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Number of patients having a benefit after this specific cardio-oncology check up and follow up

Time frame
5 years

Secondary outcomes

1

Evaluating the overall survival of patients suffering from cardiovascular or metabolic side effect of oncology treatments

Time frame
5 years
2

All relevants staisticals associations between adverse events and anticancer drugs

Time frame
5 years
3

All relevant statistical associations between cardiovascular toxicities, and anticancer drugs

Time frame
5 years
4

All relevants statistical associations between cardiovascular side effects induced by oncology treatments , and other potentials kind of side effects induced by oncology treatments

Time frame
5 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Groupe Hospitalier Pitie-Salpetriere

Lead sponsor

Source ClinicalTrials.gov
Apply now